Ecuador vs Gambia: Treatment success rate for patients treated for MDR-TB
Ecuador
65.0%
in 2022
Gambia
64.0%
in 2022
Ecuador rank
113th
Gambia rank
116th
Treatment success rate for patients treated for MDR-TB over time
- Ecuador
- Gambia
How they compare
Ecuador currently reports 65.0% against 64.0% in Gambia, a difference of 1.0%.
The two have swapped places 3 times across 6 shared years of data; in 2014 it was Gambia ahead.
Ecuador ranks 113th and Gambia ranks 116th of 163 countries.
Gambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.0% | 82.0% | 31.0% | Gambia |
| 2020s | 53.0% | 81.7% | 28.7% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Ecuador or Gambia?
- Ecuador, at 65.0% against 64.0% in Gambia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Ecuador and Gambia?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Gambia?
- 6 years are reported by both, from 2014 to 2022.
- How do Ecuador and Gambia rank globally for treatment success rate for patients treated for mdr-tb?
- Ecuador ranks 113th and Gambia ranks 116th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.